Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments

BACKGROUND: Recombinant hypoallergenic allergen derivatives have been used in clinical immunotherapy studies, and clinical efficacy seems to be related to the induction of blocking IgG antibodies recognizing the wild‐type allergens. However, so far no treatment‐induced IgG antibodies have been chara...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Allergy
Hoofdauteurs: Gadermaier, E., Marth, K., Lupinek, C., Campana, R., Hofer, G., Blatt, K., Smiljkovic, D., Roder, U., Focke‐Tejkl, M., Vrtala, S., Keller, W., Valent, P., Valenta, R., Flicker, S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2018
Onderwerpen:
ORIGINAL ARTICLES
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032869/
https://ncbi.nlm.nih.gov/pubmed/29315611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13394
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items